| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |